Yeast fungaemia among injection drug users in France (2012-2022): a cross-sectional observational study.

ABSTRACT:

Background

Intravenous injection drug use (IVDU) is an established but infrequent risk factor for yeast fungaemia. We aimed to identify features and outcomes of yeast fungaemia associated with IVDU in a nationwide surveillance network in France.

Methods

We prospectively included episodes of yeast fungaemia in adults between 2012 and 2022. Episodes with any history of IVDU were considered IVDU-associated. We compared clinical characteristics, infecting species, antifungal treatments, and 90-day mortality between groups. We used Fisher's exact test for categorical variables and the Kruskal-Wallis test for continuous variables.

Findings

We recorded 9549 episodes of yeast fungaemia among 9132 adults. Among these, 183 (1·9%) were IVDU-associated. Compared with non-IVDU, in

SUBMITTER: Paccoud O 

PROVIDER: S-EPMC12426822 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature